5,864 Shares in Azenta, Inc. (NASDAQ:AZTA) Purchased by Empowered Funds LLC

Empowered Funds LLC purchased a new position in shares of Azenta, Inc. (NASDAQ:AZTA - Free Report) during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor purchased 5,864 shares of the company's stock, valued at approximately $293,000.

A number of other large investors have also made changes to their positions in AZTA. Farther Finance Advisors LLC boosted its position in shares of Azenta by 20.0% in the 3rd quarter. Farther Finance Advisors LLC now owns 1,537 shares of the company's stock worth $74,000 after buying an additional 256 shares in the last quarter. QRG Capital Management Inc. grew its position in shares of Azenta by 6.6% in the third quarter. QRG Capital Management Inc. now owns 6,156 shares of the company's stock valued at $298,000 after purchasing an additional 383 shares during the last quarter. Ballentine Partners LLC increased its stake in shares of Azenta by 2.0% during the 4th quarter. Ballentine Partners LLC now owns 20,340 shares of the company's stock worth $1,017,000 after purchasing an additional 404 shares in the last quarter. Glenmede Trust Co. NA lifted its stake in Azenta by 6.3% in the 3rd quarter. Glenmede Trust Co. NA now owns 11,379 shares of the company's stock valued at $551,000 after buying an additional 679 shares in the last quarter. Finally, KBC Group NV increased its position in Azenta by 48.5% during the fourth quarter. KBC Group NV now owns 2,137 shares of the company's stock worth $107,000 after buying an additional 698 shares in the last quarter. Hedge funds and other institutional investors own 99.08% of the company's stock.

Analyst Ratings Changes

A number of equities analysts have recently weighed in on the stock. Needham & Company LLC boosted their price objective on shares of Azenta from $55.00 to $59.00 and gave the company a "buy" rating in a research report on Thursday, February 6th. Evercore ISI boosted their price target on Azenta from $50.00 to $52.00 and gave the company an "in-line" rating in a report on Thursday, February 6th. Finally, Stephens reissued an "overweight" rating and set a $60.00 price target on shares of Azenta in a research note on Thursday, January 2nd.

Azenta Stock Down 0.1 %

Shares of NASDAQ AZTA traded down $0.03 during trading on Friday, hitting $44.75. 423,124 shares of the company traded hands, compared to its average volume of 486,505. The firm has a market capitalization of $2.05 billion, a P/E ratio of -15.02 and a beta of 1.47. The company has a 50-day moving average price of $50.46 and a 200-day moving average price of $48.18. Azenta, Inc. has a 1 year low of $38.82 and a 1 year high of $67.77.

Azenta (NASDAQ:AZTA - Get Free Report) last issued its earnings results on Wednesday, February 5th. The company reported $0.08 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.05 by $0.03. Azenta had a positive return on equity of 1.25% and a negative net margin of 24.91%. Research analysts predict that Azenta, Inc. will post 0.53 EPS for the current fiscal year.

Azenta Profile

Azenta, Inc provides biological and chemical compound sample exploration and management solutions for the life sciences market in North America, Africa, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally. The company operates in two reportable segments, Life Sciences Products and Life Sciences Services.